She said Medtronic hopes to bring that combination to the U.S. market this calendar year, followed by developments with Abbott. “We will be addressing the sensor form factor issues and that’s going to ...

New Medtronic CFO Thierry Piéton. [Image from Mobilize Financial Services] Medtronic (NYSE: MDT) + announced today that it appointed Thierry Piéton as its new chief financial officer (CFO ...

The Medtronic Symplicty Spyral renal denervation ablation catheter expands inside the renal arteries. It ablates nerves in the vessel wall to treat hypertension. [Illustration courtesy of ...

Martha described Medtronic’s new Simplera Sync sensor as “half the size and much easier to apply than our previous sensor,” and said there are more sensors in the pipeline, as well as next-generation ...

Parkhill's exit came months after Medtronic, as part of a turnaround, decided to exit its unprofitable ventilator product line within its patient monitoring and respiratory interventions (PMRI ...

Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price target of $100.00. Discover outperforming stocks and invest ...

At the 43rd annual J.P. Morgan Healthcare Conference on Monday, Medtronic CEO Geoff Martha mixed in some breaking news with his usual pitch to investors. Just hours earlier, the Centers for ...

Medtronic’s diabetes business has turned around and is growing in the double digits, according to Martha, boosted by its technology for patients on intensive insulin therapy. The company’s Simplera ...

SAN FRANCISCO—While deep-brain stimulation therapy has been available for people with Parkinson’s disease for decades, Medtronic has now received a European approval for what it describes as ...

Among those presenting, Medtronic CEO Geoff Martha outlined multiple growth drivers in the pipeline, zeroing in on pulsed field ablation (PFA), renal denervation, neuromodulation and automated insulin ...